Novartis Europharm Limited
- A10 - Antidiabéticos
- EUCREAS film-coated tablet 1 000 mg+50 mg
- EUCREAS film-coated tablet 850 mg+50 mg
- METFORMIN AND VILDAGLIPTIN film-coated tablet 1 000 mg+50 mg
- METFORMIN AND VILDAGLIPTIN film-coated tablet 850 mg+50 mg
- STARLIX film-coated tablet 120 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- COPALIA film-coated tablet 160 mg+10 mg
- COPALIA film-coated tablet 160 mg+5 mg
- COPALIA film-coated tablet 80 mg+5 mg
- DAFIRO film-coated tablet 160 mg+10 mg
- DAFIRO film-coated tablet 160 mg+5 mg
- DAFIRO film-coated tablet 80 mg+5 mg
- ENVIAGE film-coated tablet 150 mg
- ENVIAGE film-coated tablet 300 mg
- EXFORGE film-coated tablet 160 mg+10 mg
- EXFORGE film-coated tablet 160 mg+5 mg
- EXFORGE film-coated tablet 80 mg+5 mg
- IMPRIDA film-coated tablet 160 mg+10 mg
- IMPRIDA film-coated tablet 160 mg+5 mg
- IMPRIDA film-coated tablet 80 mg+5 mg
- RASILEZ film-coated tablet 150 mg
- RASILEZ film-coated tablet 300 mg
- RIPRAZO film-coated tablet 150 mg
- RIPRAZO film-coated tablet 300 mg
- SPRIMEO film-coated tablet 150 mg
- SPRIMEO film-coated tablet 300 mg
- TEKTURNA film-coated tablet 150 mg
- TEKTURNA film-coated tablet 300 mg
- G04 - Urológicos
- EMSELEX prolonged-release tablet 15 mg
- EMSELEX prolonged-release tablet 7.5 mg
- L01 - Antineoplásicos
- TASIGNA capsule, hard 200 mg
- L03 - Inmunoestimulantes
- EXTAVIA powder and solvent for solution for injection 750 µg+3 ml
- N06 - Psicoanalépticos
- EXELON transdermal patch 4.6 mg/24 h
- EXELON transdermal patch 9.5 mg/24 h
- PROMETAX capsule, hard 1.5 mg
- PROMETAX capsule, hard 3 mg
- PROMETAX capsule, hard 4.5 mg
- PROMETAX capsule, hard 6 mg
- PROMETAX oral solution 2 mg/ml
- PROMETAX transdermal patch 4.6 mg/24 h
- PROMETAX transdermal patch 9.5 mg/24 h
- S01 - Oftalmológicos
- LUCENTIS solution for injection 3 mg/0.3 ml